| Outcome | Baseline_risk |
|---|---|
| Adverse_event | 1.6% |
| Hypoglycemia | 1.4% |
| Stroke | 1.7% |
| MI | 7.2% |
| Hba1c | 0 |
| Body_weight | 0 |
| Injection | 0 |
| Daily_glucose_testing | 0 |
| Cost | 0 |
| Nephropathy | 6.2% |
| Retinopathy | 8.9% |
| Neuropathy | 7.6% |
| Outcome | Baseline_risk |
|---|---|
| Adverse_event | 1.6% |
| Hypoglycemia | 1.4% |
| Stroke | 1.7% |
| MI | 7.2% |
| Hba1c | 0 |
| Body_weight | 0 |
| Injection | 0 |
| Daily_glucose_testing | 0 |
| Cost | 0 |
| Nephropathy | 6.2% |
| Retinopathy | 8.9% |
| Neuropathy | 7.6% |